In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Quinolor compound Drug Master File in Korea (Quinolor compound KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Quinolor compound. The MFDS reviews the Quinolor compound KDMF as part of the drug registration process and uses the information provided in the Quinolor compound KDMF to evaluate the safety and efficacy of the drug.
After submitting a Quinolor compound KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Quinolor compound API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Quinolor compound suppliers with KDMF on PharmaCompass.